Oryzon Genomics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 202,359 | 0.322% |
Private Companies | 3,147,508 | 5% |
Individual Insiders | 6,661,717 | 10.6% |
General Public | 52,929,691 | 84.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,147,508 | €4.7m | 0% | no data | |||
2,903,042 | €4.4m | 0% | no data | |||
2,493,560 | €3.8m | 0% | no data | |||
1,246,780 | €1.9m | 0% | no data | |||
79,553 | €120.0k | 0% | no data | |||
47,867 | €72.2k | 0% | 0.01% | |||
45,023 | €67.9k | 0% | 0.06% | |||
19,905 | €30.0k | 0% | 0.34% | |||
18,335 | €27.6k | 0% | no data | |||
8,056 | €12.1k | 0% | no data | |||
1,955 | €3.0k | 0% | no data |